Sai Life Sciences Limited — Others, 14-05-2025: Monitoring Agency Report

Sai Life Sciences has announced a monitoring agency report on IPO proceeds utilization. The company raised Rs 950 crore from a total issue of Rs 3,042.62 crore. Of the proceeds, Rs 720 crore has been fully used for debt repayment, while Rs 190 crore is allocated for general corporate purposes, with around Rs 71.95 crore spent this quarter on equipment, salaries, and operations. Rs 148.43 crore remains unutilized in fixed deposits and bank accounts. The report confirms disciplined capital deployment aligned with growth and financial stability.